Adults 18+ with a BMI of 27 or higher, or 25+ with weight-related conditions Patients who have plateaued on a single-agonist GLP-1 and want to escalate under supervision Members for whom faster onset and higher trial averages are clinically appropriate Personal or family history of medullary thyroid carcinoma or MEN 2 Pregnancy, breastfeeding, or planning pregnancy Active pancreatitis or untreated severe gastrointestinal disease IIIExpected Timeline What to Expect Tirzepatide tends to act faster and reach further than single-agonist GLP-1s
Dumping syndrome after esophageal, gastric or bariatric surgery: pathophysiology, diagnosis, and management
It maintains blood vessels and connective tissues and supports the musculoskeletal system
Ongoing Support : Once authorized, enjoy 24/7 care coordination
AC230280050 Supplier Thermo Scientific Chemicals Supplier No
For longer-standing issues, the full benefit typically develops over a complete 8-week cycle